Medtronic receives FDA clearance for Hugo robotic-assisted surgery system

Evidence notes

• Medtronic received U.S. FDA clearance for the Hugo robotic-assisted surgery system for urologic procedures.
• The clearance was supported by the Expand URO clinical study in multi-port robotic-assisted urological surgery.
• The decision brings Hugo into the U.S. soft-tissue robotic surgery market alongside Medtronic's broader surgical portfolio.